Document is current

Article History

First Online: 28 May 2020

Compliance with ethical standards

:

: DF: lecture honoraria and advisory board fees from Abbott Laboratories, Bayer, Boehringer Ingelheim, Menarini, Novartis, Orion Pharma and Roche Diagnostics; CC: honoraria from Boehringer Ingelheim and Novartis; G. Giamouzis: honoraria from Bayer, Boehringer Ingelheim and Pfizer; G. Giannakoulas: lecture honoraria and/or advisory boards from AstraZeneca, Bayer, Boehringer Ingelheim, ELPEN Pharmaceuticals, Genesis Pharma, Novartis, Pfizer, Roche and Servier; MH: honoraria from Astra Zeneca, Boehringer Ingelheim, Pfizer and Sanofi; KN: honoraria for participation in a clinical trial and contribution to advisory boards (all minor) from Boehringer Ingelheim; ST: lecture honoraria from Bayer, Boehringer Ingelheim and Pfizer; SX: lecture honoraria from Bayer, Boehringer Ingelheim, Merck, Novartis, Pfizer and Servier and advisory board fees from Boehringer Ingelheim, Novartis and Servier; AK: lectures honoraria and advisory board fees from Boehringer Ingelheim, Elpen, Genesis Pharma, Menarini, Novartis, Pfizer, Sanofi and Servier; JP: honoraria from Boehringer Ingelheim, Novartis, Pfizer, Roche Diagnostics and Servier.